Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study
<p><strong>Background:</strong> Individuals with comorbidities are at increased risk of severe respiratory syncytial virus (RSV) infection. We estimated RSV-associated respiratory hospitalization among adults aged ≥45 years with comorbidities in Denmark and Scotland.</p> <...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2024
|
| _version_ | 1797113271549952000 |
|---|---|
| author | Osei-Yeboah, R Johannesen, CK Egeskov-Cavling, AM Chen, J Lehtonen, T Fornes, AU Paget, J Fischer, TK Wang, X Nair, H Campbell, H |
| author2 | PROMISE Investigators |
| author_facet | PROMISE Investigators Osei-Yeboah, R Johannesen, CK Egeskov-Cavling, AM Chen, J Lehtonen, T Fornes, AU Paget, J Fischer, TK Wang, X Nair, H Campbell, H |
| author_sort | Osei-Yeboah, R |
| collection | OXFORD |
| description | <p><strong>Background:</strong> Individuals with comorbidities are at increased risk of severe respiratory syncytial virus (RSV) infection. We estimated RSV-associated respiratory hospitalization among adults aged ≥45 years with comorbidities in Denmark and Scotland.</p>
<p><strong>Methods:</strong> By analyzing national hospital and virologic data, we estimated annual RSV-associated hospitalizations by 7 selected comorbidities and ages between 2010 and 2018. We estimated rate ratios of RSV-associated hospitalization for adults with comorbidity than the overall population.</p>
<p><strong>Results:</strong> In Denmark, annual RSV–associated hospitalization rates per 1000 adults ranged from 3.1 for asthma to 19.4 for chronic kidney disease (CKD). In Scotland, rates ranged from 2.4 for chronic liver disease to 9.0 for chronic obstructive pulmonary disease (COPD). In both countries, we found a 2- to 4-fold increased risk of RSV hospitalization for adults with COPD, ischemic heart disease, stroke, and diabetes; a 1.5- to 3-fold increased risk for asthma; and a 3- to 7-fold increased risk for CKD. RSV hospitalization rates among adults aged 45 to 64 years with COPD, asthma, ischemic heart disease, or CKD were higher than the overall population.</p>
<p><strong>Conclusions:</strong> This study provides important evidence for identifying risk groups and assisting health authorities in RSV vaccination policy making.</p> |
| first_indexed | 2024-04-09T03:58:17Z |
| format | Journal article |
| id | oxford-uuid:ad04b332-9841-4ce2-a5d2-8355fecb44fc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-04-23T08:26:10Z |
| publishDate | 2024 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:ad04b332-9841-4ce2-a5d2-8355fecb44fc2024-04-18T14:09:07ZRespiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ad04b332-9841-4ce2-a5d2-8355fecb44fcEnglishSymplectic ElementsOxford University Press2024Osei-Yeboah, RJohannesen, CKEgeskov-Cavling, AMChen, JLehtonen, TFornes, AUPaget, JFischer, TKWang, XNair, HCampbell, HPROMISE InvestigatorsPollard, AJ<p><strong>Background:</strong> Individuals with comorbidities are at increased risk of severe respiratory syncytial virus (RSV) infection. We estimated RSV-associated respiratory hospitalization among adults aged ≥45 years with comorbidities in Denmark and Scotland.</p> <p><strong>Methods:</strong> By analyzing national hospital and virologic data, we estimated annual RSV-associated hospitalizations by 7 selected comorbidities and ages between 2010 and 2018. We estimated rate ratios of RSV-associated hospitalization for adults with comorbidity than the overall population.</p> <p><strong>Results:</strong> In Denmark, annual RSV–associated hospitalization rates per 1000 adults ranged from 3.1 for asthma to 19.4 for chronic kidney disease (CKD). In Scotland, rates ranged from 2.4 for chronic liver disease to 9.0 for chronic obstructive pulmonary disease (COPD). In both countries, we found a 2- to 4-fold increased risk of RSV hospitalization for adults with COPD, ischemic heart disease, stroke, and diabetes; a 1.5- to 3-fold increased risk for asthma; and a 3- to 7-fold increased risk for CKD. RSV hospitalization rates among adults aged 45 to 64 years with COPD, asthma, ischemic heart disease, or CKD were higher than the overall population.</p> <p><strong>Conclusions:</strong> This study provides important evidence for identifying risk groups and assisting health authorities in RSV vaccination policy making.</p> |
| spellingShingle | Osei-Yeboah, R Johannesen, CK Egeskov-Cavling, AM Chen, J Lehtonen, T Fornes, AU Paget, J Fischer, TK Wang, X Nair, H Campbell, H Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title | Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title_full | Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title_fullStr | Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title_full_unstemmed | Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title_short | Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study |
| title_sort | respiratory syncytial virus associated hospitalization in adults with comorbidities in 2 european countries a modeling study |
| work_keys_str_mv | AT oseiyeboahr respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT johannesenck respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT egeskovcavlingam respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT chenj respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT lehtonent respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT fornesau respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT pagetj respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT fischertk respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT wangx respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT nairh respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy AT campbellh respiratorysyncytialvirusassociatedhospitalizationinadultswithcomorbiditiesin2europeancountriesamodelingstudy |